Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pérol

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2013
Reply to N. Singh et alMaurice Pérol, David Pérol, Christos Chouaid
Annals of Surgery|March 21, 2014
Reply to Letter: "Adhesiolysis and Adhesion Prevention in 2-Stage Surgery"Aurélien Dupré, David Pérol, Michel Rivoire
Lancet (London, England)|August 19, 2014
Adhesion barriers for abdominal surgery and oncologyAurélien Dupré, David Pérol, Michel Rivoire
The New England Journal of Medicine|April 16, 2020
PARP Inhibitors in Ovarian Cancer. ReplyIsabelle Ray-Coquard, David Pérol, Eric Pujade-Lauraine
BMJ (Clinical Research Ed.)|December 18, 2016
Routinely collected data may usefully supplement randomised controlled data on treatment effects for mortalityDavid Pérol, Mathieu Robain, Suzette Delaloge, et al.
Critical Reviews in Oncology/Hematology|March 27, 2010
Quality of life in geriatric oncology--An evaluation of standard questionnaires in elderly men with urological malignanciesCatherine Terret, David Pérol, Gilles Albrand, et al.
BMC Medical Research Methodology|November 3, 2025
Enhancing confidence in complex health technology assessments by using real-world evidence: highlighting existing strategies for effective drug evaluationAlison Antoine, Katia Desroziers, Julien Dupin, et al.
Plos One|October 11, 2021
Using numerical modeling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sampleJean-Pierre Boissel, David Pérol, Hervé Décousus, et al.
Contemporary Clinical Trials|July 7, 2009
Revisiting the level of evidence in randomized controlled clinical trials: A simulation approachAgathe Bajard, Sylvie Chabaud, David Pérol, et al.
Clinical and Translational Radiation Oncology|July 13, 2023
Cicaderma® in radiation-related dermatitis of breast cancer: Results from the multicentric randomised phase III CICA-RTSéverine Racadot, Antoine Arnaud, Camille Schiffler, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2013
Reply to N. Singh et alMaurice Pérol, David Pérol, Christos Chouaid
Annals of Surgery|March 21, 2014
Reply to Letter: "Adhesiolysis and Adhesion Prevention in 2-Stage Surgery"Aurélien Dupré, David Pérol, Michel Rivoire
Lancet (London, England)|August 19, 2014
Adhesion barriers for abdominal surgery and oncologyAurélien Dupré, David Pérol, Michel Rivoire
The New England Journal of Medicine|April 16, 2020
PARP Inhibitors in Ovarian Cancer. ReplyIsabelle Ray-Coquard, David Pérol, Eric Pujade-Lauraine
BMJ (Clinical Research Ed.)|December 18, 2016
Routinely collected data may usefully supplement randomised controlled data on treatment effects for mortalityDavid Pérol, Mathieu Robain, Suzette Delaloge, et al.
Critical Reviews in Oncology/Hematology|March 27, 2010
Quality of life in geriatric oncology--An evaluation of standard questionnaires in elderly men with urological malignanciesCatherine Terret, David Pérol, Gilles Albrand, et al.
BMC Medical Research Methodology|November 3, 2025
Enhancing confidence in complex health technology assessments by using real-world evidence: highlighting existing strategies for effective drug evaluationAlison Antoine, Katia Desroziers, Julien Dupin, et al.
Plos One|October 11, 2021
Using numerical modeling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sampleJean-Pierre Boissel, David Pérol, Hervé Décousus, et al.
Contemporary Clinical Trials|July 7, 2009
Revisiting the level of evidence in randomized controlled clinical trials: A simulation approachAgathe Bajard, Sylvie Chabaud, David Pérol, et al.
Clinical and Translational Radiation Oncology|July 13, 2023
Cicaderma® in radiation-related dermatitis of breast cancer: Results from the multicentric randomised phase III CICA-RTSéverine Racadot, Antoine Arnaud, Camille Schiffler, et al.
Pageof 11